Search of: A Phase Ii Study of Cyclophosphamide, Etoposide, Vincristine And Prednisone (CEOP) Alternating With Pralatrexate (P) As Front Line Therapy For Patients With Stage Ii, Iii And Iv Peripheral T-Cell Non-Hodgkin’s Lymphoma - List Results

1 study found for: A Phase Ii Study of Cyclophosphamide, Etoposide, Vincristine And Prednisone (CEOP) Alternating With Pralatrexate (P) As Front Line Therapy For Patients With Stage Ii, Iii And Iv Peripheral T-Cell Non-Hodgkin’s Lymphoma

Modify this search | How to Use Search Results

Show Display Options

Download

Rank

Status

Study

Active, not recruiting

Combination Chemotherapy and Pralatrexate as First-Line Therapy in Treating Patients With Non-Hodgkin Lymphoma

Conditions:	Anaplastic Large Cell Lymphoma; Angioimmunoblastic T-cell Lymphoma; Hepatosplenic T-cell Lymphoma; Peripheral T-cell Lymphoma
Interventions:	Drug: prednisone; Drug: cyclophosphamide; Drug: etoposide; Drug: vincristine sulfate; Drug: pralatrexate; Other: laboratory biomarker analysis; Genetic: comparative genomic hybridization; Genetic: gene expression analysis; Genetic: nucleic acid sequencing; Genetic: mutation analysis; Other: immunohistochemistry staining method; Genetic: microarray analysis; Genetic: RNA analysis

To Top